Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 October 2019 | Story Valentino Ndaba | Photo Barend Nagel
BCom degree
Prospective students are invited to apply for the new BCom Business and Financial Analytics 2020 intake.

A new qualification has recently been added to the University of the Free State (UFS) curriculum and 30 prospective students still have the opportunity to form part of the BCom with specialisation in Business and Financial Analytics intake for 2020. The deadline for applications has been extended to 31 October 2019. 

Committed to the 4th industrial revolution

This flagship degree has been designed for the 4th Industrial Revolution as it integrates quantitative analysis, computer science, statistics and business. This new qualification will equip graduates to become high-functioning executives in the modern global business world. 

“The Faculty of Economic and Management Sciences identified the need for a BCom programme incorporating some of these skills in a more deliberate way, in order to prepare our graduates for a changing job market,” says Lizette Pretorius, Faculty Manager.

On par with global standards

International institutions such as Harvard Business School, Carnegie Mellon University, Duke University, and Columbia University have led the way by adopting this cohesive approach to business studies. These universities form part of a listing of the 25 top US schools offering Master’s in Business Analytics programmes. 

The UFS is following in these leading institutions as part of its Integrated Transformation Plan (ITP) to produce globally competitive graduates. According to the ITP: “The future state of engaged scholarship will be an important anchor in maintaining the relevance of the academic syllabus, and linking real local needs to the global knowledge project.”

 Click here to complete the application form. 

Please email the form and required documents to Lizette Pretorius at LPretorius@ufs.ac.za.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept